Adverse effects of advanced glycation end products on embryonal development

Lin Hao, Soichi Noguchi, Yasuhiko Kamada, Aiko Sasaki, Miwa Matsuda, Keiko Shimizu, Yuji Hiramatsu, Mikiya Nakatsuka

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We studied the effects of advanced glycation end products (AGEs), which are known to accumulate in patients with diabetes, autoimmune diseases, or those who smoke, on embryonal development. Pronuclear (PN) embryos were obtained by flushing the fallopian tubes of rats after superovulation and mating. The cleavage rate and blastocyst yield were evaluated at 24, 72, 96, and 120 h of culture. Glyoxal, an AGE-forming aldehyde, suppressed embryonal development at every stage from PN to blastocyst in a concentration-dependent manner. The cleavage rate of the embryo was also significantly decreased by treatment with glyoxal at concentrations of 1 mM or higher. The blastocyst yield was significantly decreased by treatment with glyoxal at concentrations of 0.5 mM or higher. N-acetyl-L-cysteine (L-NAC) at 1 mM significantly suppressed the glyoxal-induced embryonal toxicity. BSA-AGEs at 5 μg/ml or higher concentration significantly reduced the cleavage rate and blastocyst yield compared to those for BSA-treated embryos. L-NAC at 1 mM significantly suppressed BSA-AGE-induced embryonal toxicity. Because AGEs are embryo-toxic, AGE contamination may influence the pregnancy rate of in vitro fertilization and embryo transfer. AGEs, which are increased in women under pathological conditions, may also be involved in their infertility. Copyright

Original languageEnglish
Article number4
Pages (from-to)93-99
Number of pages7
JournalActa medica Okayama
Volume62
Issue number2
Publication statusPublished - Apr 1 2008

Keywords

  • Advanced glycation end products
  • Blastocyst
  • Embryo
  • In vitro fertilization
  • N-acetyl-L-cysteine

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Adverse effects of advanced glycation end products on embryonal development'. Together they form a unique fingerprint.

  • Cite this

    Hao, L., Noguchi, S., Kamada, Y., Sasaki, A., Matsuda, M., Shimizu, K., Hiramatsu, Y., & Nakatsuka, M. (2008). Adverse effects of advanced glycation end products on embryonal development. Acta medica Okayama, 62(2), 93-99. [4].